Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies.

Papola D, Ostuzzi G, Gastaldon C, Morgano GP, Dragioti E, Carvalho AF, Fusar-Poli P, Correll CU, Solmi M, Barbui C.

Acta Psychiatr Scand. 2019 Jul 2. doi: 10.1111/acps.13066. [Epub ahead of print]

PMID:
31264708
2.

Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis.

Caruso R, Ostuzzi G, Turrini G, Ballette F, Recla E, DallʼOlio R, Croce E, Casoni B, Grassi L, Barbui C.

Pain. 2019 May 22. doi: 10.1097/j.pain.0000000000001622. [Epub ahead of print]

PMID:
31145210
3.

Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials.

Purgato M, Carswell K, Acarturk C, Au T, Akbai S, Anttila M, Baumgartner J, Bailey D, Biondi M, Bird M, Churchill R, Eskici S, Hansen LJ, Heron P, Ilkkursun Z, Kilian R, Koesters M, Lantta T, Nosè M, Ostuzzi G, Papola D, Popa M, Sijbrandij M, Tarsitani L, Tedeschi F, Turrini G, Uygun E, Välimäki MA, Wancata J, White R, Zanini E, Cuijpers P, Barbui C, Van Ommeren M.

BMJ Open. 2019 May 14;9(5):e030259. doi: 10.1136/bmjopen-2019-030259.

4.

Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence.

Godman B, Kurdi A, McCabe H, Johnson CF, Barbui C, MacBride-Stewart S, Hurding S, Leporowski A, Bennie M, Morton A.

J Comp Eff Res. 2019 May;8(7):535-547. doi: 10.2217/cer-2018-0132. Epub 2019 Apr 26.

PMID:
31023070
5.

Benzodiazepines versus placebo for panic disorder in adults.

Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJ, Furukawa TA, Koesters M.

Cochrane Database Syst Rev. 2019 Mar 28;3:CD010677. doi: 10.1002/14651858.CD010677.pub2.

PMID:
30921478
6.

Psychological and Psychosomatic Symptoms of Second Victims of Adverse Events: a Systematic Review and Meta-Analysis.

Busch IM, Moretti F, Purgato M, Barbui C, Wu AW, Rimondini M.

J Patient Saf. 2019 Mar 26. doi: 10.1097/PTS.0000000000000589. [Epub ahead of print]

PMID:
30921046
7.

Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis.

Turrini G, Purgato M, Acarturk C, Anttila M, Au T, Ballette F, Bird M, Carswell K, Churchill R, Cuijpers P, Hall J, Hansen LJ, Kösters M, Lantta T, Nosè M, Ostuzzi G, Sijbrandij M, Tedeschi F, Valimaki M, Wancata J, White R, van Ommeren M, Barbui C.

Epidemiol Psychiatr Sci. 2019 Aug;28(4):376-388. doi: 10.1017/S2045796019000027. Epub 2019 Feb 11.

PMID:
30739625
8.

Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis.

Ostuzzi G, Turrini G, Gastaldon C, Papola D, Rayner L, Caruso R, Grassi L, Hotopf M, Barbui C.

Int Clin Psychopharmacol. 2019 Mar;34(2):65-75. doi: 10.1097/YIC.0000000000000248.

PMID:
30531552
9.

Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis.

Bighelli I, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, Schwermann F, Pitschel-Walz G, Barbui C, Furukawa TA, Leucht S.

BMC Psychiatry. 2018 Dec 4;18(1):380. doi: 10.1186/s12888-018-1964-8.

10.

The Italian mental health-care reform: public health lessons.

Barbui C, Papola D, Saraceno B.

Bull World Health Organ. 2018 Nov 1;96(11):731-731A. doi: 10.2471/BLT.18.216002. No abstract available.

11.

Supplementary Data

Amato L, Vecchi S, Barbui C, Cruciani F, D'Amico R, Del Giovane C, Minozzi S, Mitrova Z, Saulle R, Davoli M.

Recenti Prog Med. 2018 Oct;109(10):1e-19e. doi: 10.1701/3010.30090. Italian. No abstract available.

PMID:
30394409
12.

[Systematic review to evaluate the efficacy, acceptability and safety of second-generation antipsychotics for the treatment of unipolar and bipolar depression.]

Amato L, Vecchi S, Barbui C, Cruciani F, D'Amico R, Del Giovane C, Minozzi S, Mitrova Z, Saulle R, Davoli M.

Recenti Prog Med. 2018 Oct;109(10):474-486. doi: 10.1701/3010.30085. Italian.

PMID:
30394408
13.

Global mental health: how are we doing?

Hanna F, Barbui C, Dua T, Lora A, van Regteren Altena M, Saxena S.

World Psychiatry. 2018 Oct;17(3):367-368. doi: 10.1002/wps.20572. No abstract available.

14.

Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis.

Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, Schwermann F, Pitschel-Walz G, Barbui C, Furukawa TA, Leucht S.

World Psychiatry. 2018 Oct;17(3):316-329. doi: 10.1002/wps.20577.

15.

Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future.

Mahmood S, Hussain S, Ur Rehman T, Barbui C, Kurdi AB, Godman B.

Curr Med Res Opin. 2018 Sep 20:1-11. doi: 10.1080/03007995.2018.1513834. [Epub ahead of print]

PMID:
30122062
16.

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.

Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A.

Lancet Psychiatry. 2018 Sep;5(9):727-738. doi: 10.1016/S2215-0366(18)30269-4. Epub 2018 Aug 7.

17.

Forty years without mental hospitals in Italy.

Barbui C, Papola D, Saraceno B.

Int J Ment Health Syst. 2018 Jul 31;12:43. doi: 10.1186/s13033-018-0223-1. eCollection 2018.

18.

Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.

Ostuzzi G, Mazzi MA, Terlizzi S, Bertolini F, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, Gastaldon C, Lucii C, Magliocco F, Martinotti G, Nosé M, Ostinelli EG, Papola D, Piccinelli MP, Piccoli A, Purgato M, Tabacchi T, Turrini G, Ruggeri M, Barbui C; STAR Network Investigators.

PLoS One. 2018 Aug 2;13(8):e0201371. doi: 10.1371/journal.pone.0201371. eCollection 2018.

19.

Medicine-based evidence: the case of antidepressants in patients with coronary artery disease.

Barbui C, Ostuzzi G.

Epidemiol Psychiatr Sci. 2019 Feb;28(1):18-20. doi: 10.1017/S2045796018000380. Epub 2018 Jul 30.

PMID:
30058526
20.

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil.

Barbosa WB, Costa JO, de Lemos LLP, Gomes RM, de Oliveira HN, Ruas CM, Acurcio FA, Barbui C, Bennie M, Godman B, Guerra AA Jr.

Appl Health Econ Health Policy. 2018 Oct;16(5):697-709. doi: 10.1007/s40258-018-0408-4.

21.

Safety of psychotropic medicines: looking beyond randomised evidence.

Barbui C, Patten SB.

Epidemiol Psychiatr Sci. 2018 Dec;27(6):529-530. doi: 10.1017/S2045796018000306. Epub 2018 Jul 13. No abstract available.

PMID:
30001764
22.

Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises.

Purgato M, Gastaldon C, Papola D, van Ommeren M, Barbui C, Tol WA.

Cochrane Database Syst Rev. 2018 Jul 5;7:CD011849. doi: 10.1002/14651858.CD011849.pub2. Review.

23.

Recent approaches to provision of mental healthcare in refugee populations.

Koesters M, Barbui C, Purgato M.

Curr Opin Psychiatry. 2018 Jul;31(4):368-372. doi: 10.1097/YCO.0000000000000428. Review.

PMID:
29708893
24.

Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies.

Papola D, Ostuzzi G, Thabane L, Guyatt G, Barbui C.

Int Clin Psychopharmacol. 2018 Jul;33(4):181-196. doi: 10.1097/YIC.0000000000000221.

PMID:
29688914
25.

Antidepressants for the treatment of depression in people with cancer.

Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2018 Apr 23;4:CD011006. doi: 10.1002/14651858.CD011006.pub3. Review.

26.

Antidepressants versus placebo for panic disorder in adults.

Bighelli I, Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G, Furukawa TA, Barbui C.

Cochrane Database Syst Rev. 2018 Apr 5;4:CD010676. doi: 10.1002/14651858.CD010676.pub2. Review.

27.

Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials.

Bighelli I, Salanti G, Reitmeir C, Wallis S, Barbui C, Furukawa TA, Leucht S.

BMJ Open. 2018 Mar 14;8(3):e019280. doi: 10.1136/bmjopen-2017-019280.

28.

Focused psychosocial interventions for children in low-resource humanitarian settings: a systematic review and individual participant data meta-analysis.

Purgato M, Gross AL, Betancourt T, Bolton P, Bonetto C, Gastaldon C, Gordon J, O'Callaghan P, Papola D, Peltonen K, Punamaki RL, Richards J, Staples JK, Unterhitzenberger J, van Ommeren M, de Jong J, Jordans MJD, Tol WA, Barbui C.

Lancet Glob Health. 2018 Apr;6(4):e390-e400. doi: 10.1016/S2214-109X(18)30046-9. Review.

29.

Celebrating the 40th anniversary of the Italian Mental Health reform.

Amaddeo F, Barbui C.

Epidemiol Psychiatr Sci. 2018 Aug;27(4):311-313. doi: 10.1017/S2045796018000112. Epub 2018 Mar 13. No abstract available.

PMID:
29530111
30.

Does mental health staffing level affect antipsychotic prescribing? Analysis of Italian national statistics.

Starace F, Mungai F, Barbui C.

PLoS One. 2018 Feb 21;13(2):e0193216. doi: 10.1371/journal.pone.0193216. eCollection 2018.

31.

Access to and Use of Psychiatric Services by Migrants Resettled in Northern Italy.

Cristofalo D, Bonetto C, Ballarin M, Amaddeo F, Ruggeri M, Nosè M, Barbui C.

J Immigr Minor Health. 2018 Dec;20(6):1309-1316. doi: 10.1007/s10903-018-0703-z.

PMID:
29354861
32.

Psychotherapies for depression in low- and middle-income countries: a meta-analysis.

Cuijpers P, Karyotaki E, Reijnders M, Purgato M, Barbui C.

World Psychiatry. 2018 Feb;17(1):90-101. doi: 10.1002/wps.20493.

33.

Public health psychopharmacology: a new research discipline comes of age?

Barbui C, Ostuzzi G, Godman B.

Epidemiol Psychiatr Sci. 2018 Feb;27(1):24-28. doi: 10.1017/S2045796017000464.

34.

Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance.

Ostuzzi G, Barbui C, Hanlon C, Chatterjee S, Eaton J, Jones L, Silove D, Ventevogel P.

BMC Med. 2017 Dec 11;15(1):197. doi: 10.1186/s12916-017-0960-z.

35.

Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature.

Meid AD, Bighelli I, Mächler S, Mikus G, Carrà G, Castellazzi M, Lucii C, Martinotti G, Nosè M, Ostuzzi G, Barbui C, Haefeli WE.

Ther Adv Psychopharmacol. 2017 Dec;7(12):251-264. doi: 10.1177/2045125317721662. Epub 2017 Aug 28.

36.

WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: a systematic review of evidence from low and middle-income countries.

Keynejad RC, Dua T, Barbui C, Thornicroft G.

Evid Based Ment Health. 2018 Feb;21(1):30-34. doi: 10.1136/eb-2017-102750. Epub 2017 Sep 13. Review.

PMID:
28903977
37.

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies.

Turrini G, Purgato M, Ballette F, Nosè M, Ostuzzi G, Barbui C.

Int J Ment Health Syst. 2017 Aug 25;11:51. doi: 10.1186/s13033-017-0156-0. eCollection 2017.

38.

Regulatory meta-analyses for the evaluation of psychotropic medicines.

Barbui C, Purgato M, Ostuzzi G.

Lancet Psychiatry. 2017 Sep;4(9):660-661. doi: 10.1016/S2215-0366(17)30161-X. No abstract available.

PMID:
28853404
39.

Prevalence and Correlates of Psychological Distress and Psychiatric Disorders in Asylum Seekers and Refugees Resettled in an Italian Catchment Area.

Nosè M, Turrini G, Imoli M, Ballette F, Ostuzzi G, Cucchi F, Padoan C, Ruggeri M, Barbui C.

J Immigr Minor Health. 2018 Apr;20(2):263-270. doi: 10.1007/s10903-017-0629-x.

PMID:
28730398
40.

Vortioxetine for depression in adults.

Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C.

Cochrane Database Syst Rev. 2017 Jul 5;7:CD011520. doi: 10.1002/14651858.CD011520.pub2. Review.

41.

Reviews and Meta-analyses of Psychotherapy Efficacy for Borderline Personality Disorder-Reply.

Cristea IA, Barbui C, Cuijpers P.

JAMA Psychiatry. 2017 Aug 1;74(8):854-855. doi: 10.1001/jamapsychiatry.2017.1403. No abstract available.

PMID:
28636723
42.

Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysis.

Bighelli I, Borghesani A, Barbui C.

PLoS One. 2017 Jun 2;12(6):e0178617. doi: 10.1371/journal.pone.0178617. eCollection 2017. Review.

43.

Evidence-based interventions for global mental health: role and mission of a new Cochrane initiative.

Barbui C, Purgato M, Churchill R, Adams CE, Amato L, Macdonald G, McCleery J, Minozzi S, Sheriff RS.

Cochrane Database Syst Rev. 2017 Apr 21;4:ED000120. doi: 10.1002/14651858.ED000120. No abstract available.

PMID:
28453184
44.

Cochrane for global mental health.

Barbui C, Purgato M, Churchill R, Adams C, Amato L, Macdonald G, McCleery J, Minozzi S, Sheriff RS.

Lancet Psychiatry. 2017 Apr;4(4):e6. doi: 10.1016/S2215-0366(17)30090-1. No abstract available.

PMID:
28347436
45.

Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis.

Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P.

JAMA Psychiatry. 2017 Apr 1;74(4):319-328. doi: 10.1001/jamapsychiatry.2016.4287. Review.

PMID:
28249086
46.

Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis.

Nosè M, Ballette F, Bighelli I, Turrini G, Purgato M, Tol W, Priebe S, Barbui C.

PLoS One. 2017 Feb 2;12(2):e0171030. doi: 10.1371/journal.pone.0171030. eCollection 2017.

47.

A systematic review of cognitive effects of exercise in depression.

Brondino N, Rocchetti M, Fusar-Poli L, Codrons E, Correale L, Vandoni M, Barbui C, Politi P.

Acta Psychiatr Scand. 2017 Apr;135(4):285-295. doi: 10.1111/acps.12690. Epub 2017 Jan 22. Review.

PMID:
28110494
48.

Evidence, knowledge, implementation: glossary of terminology.

Barbui C.

Epidemiol Psychiatr Sci. 2017 Jan 19:1-2. doi: 10.1017/S2045796016001037. [Epub ahead of print] No abstract available.

PMID:
28100292
49.

Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.

Cortese S, Adamo N, Mohr-Jensen C, Hayes AJ, Bhatti S, Carucci S, Del Giovane C, Atkinson LZ, Banaschewski T, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A, Coghill D; European ADHD Guidelines Group (EAGG).

BMJ Open. 2017 Jan 10;7(1):e013967. doi: 10.1136/bmjopen-2016-013967.

50.

Mapping actions to improve access to medicines for mental disorders in low and middle income countries.

Barbui C, Dua T, Kolappa K, Saraceno B, Saxena S.

Epidemiol Psychiatr Sci. 2017 Oct;26(5):481-490. doi: 10.1017/S2045796016001165. Epub 2017 Jan 9.

PMID:
28067194

Supplemental Content

Loading ...
Support Center